Bosh sahifaBOT • ASX
add
Botanix Pharmaceuticals Ltd
Yopilish kursi
0,42 $
Kunlik diapazon
0,41 $ - 0,43 $
Yillik diapazon
0,18 $ - 0,54 $
Bozor kapitalizatsiyasi
776,10 mln AUD
Oʻrtacha hajm
8,89 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ASX
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 188,80 ming | -0,09% |
Joriy xarajat | 15,57 mln | 532,16% |
Sof foyda | -15,44 mln | -464,98% |
Sof foyda marjasi | -8,18 ming | -465,47% |
Har bir ulushga tushum | — | — |
EBITDA | -15,43 mln | -459,15% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 48,44 mln | 164,49% |
Jami aktivlari | 99,45 mln | 108,57% |
Jami passivlari | 6,96 mln | 203,76% |
Umumiy kapital | 92,49 mln | — |
Tarqatilgan aksiyalar | 1,82 mlrd | — |
Narxi/balansdagi bahosi | 8,30 | — |
Aktivlardan daromad | -40,19% | — |
Kapitaldan daromad | -42,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -15,44 mln | -464,98% |
Operatsiyalardan naqd pul | -15,28 mln | -712,75% |
Sarmoyadan naqd pul | -426,99 ming | 94,22% |
Moliyadan naqd pul | 200,20 ming | -98,50% |
Naqd pulning sof oʻzgarishi | -15,44 mln | -482,88% |
Boʻsh pul | -4,57 mln | 45,34% |
Haqida
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Tashkil etilgan
1984
Xodimlar soni
11
